BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2010;17:476-489. [PMID: 19851704 DOI: 10.1007/s00534-009-0204-5] [Cited by in Crossref: 165] [Cited by in F6Publishing: 145] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43:32-41. [PMID: 27283892 DOI: 10.1016/j.ejso.2016.05.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
2 Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol 2016;51:153-61. [PMID: 26187429 DOI: 10.1007/s00535-015-1103-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
3 Yang M, Li WW, Chen JH, Cui MH, Liu JL. The value of caudate lobectomy in hilar cholangiocarcinoma treatment: A meta-analysis. Medicine (Baltimore) 2021;100:e24727. [PMID: 33607815 DOI: 10.1097/MD.0000000000024727] [Reference Citation Analysis]
4 Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257:191-204. [PMID: 23013805 DOI: 10.1097/sla.0b013e31826f4b0e] [Cited by in Crossref: 107] [Cited by in F6Publishing: 46] [Article Influence: 11.9] [Reference Citation Analysis]
5 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
6 Higuchi R, Yazawa T, Uemura S, Izumo W, Ota T, Kiyohara K, Furukawa T, Egawa H, Yamamoto M. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion. J Gastrointest Surg 2019;23:1443-53. [PMID: 30203230 DOI: 10.1007/s11605-018-3948-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Nam HS, Kang DH. Current Status of Biliary Metal Stents. Clin Endosc 2016;49:124-30. [PMID: 26911896 DOI: 10.5946/ce.2016.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hu HJ, Zhou RX, Shrestha A, Tan YQ, Ma WJ, Yang Q, Lu J, Wang JK, Zhou Y, Li FY. Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma. Oncotarget 2017;8:105011-9. [PMID: 29285229 DOI: 10.18632/oncotarget.22054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Jingdong L, Yongfu X, Yang G, Jian X, Xujian H, Jianhua L, Wenxing Z, Renyi Q, Xinming Y, Shuguo Z, Xiao L, Bin P, Qifan Z, Dewei L, Zhao-Hui T. Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients. Surg Endosc 2020. [PMID: 33258033 DOI: 10.1007/s00464-020-08161-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Miyagawa S. Surgical Treatment of 144 Cases of Hilar Cholangiocarcinoma Without Liver-Related Mortality. World J Surg 2014;38:1164-76. [DOI: 10.1007/s00268-013-2394-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
11 Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR, Coelen RJ, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Jarnagin WR, van Gulik TM. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015;221:1041-1049. [PMID: 26454735 DOI: 10.1016/j.jamcollsurg.2015.09.005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 10.3] [Reference Citation Analysis]
12 Ito T, Butler JR, Noguchi D, Ha M, Aziz A, Agopian VG, DiNorcia J 3rd, Yersiz H, Farmer DG, Busuttil RW, Hong JC, Kaldas FM. A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy. Liver Transpl 2021. [PMID: 34482610 DOI: 10.1002/lt.26285] [Reference Citation Analysis]
13 Tian Y, Liu L, Yeolkar NV, Shen F, Li J, He Z. Diagnostic role of staging laparoscopy in a subset of biliary cancers: a meta-analysis. ANZ J Surg. 2017;87:22-27. [PMID: 27647697 DOI: 10.1111/ans.13762] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
14 Kang MJ, Jang JY, Chang J, Shin YC, Lee D, Kim HB, Kim SW. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. World J Surg. 2016;40:2451-2459. [PMID: 27206402 DOI: 10.1007/s00268-016-3551-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
15 Wang Y, Duan B, Yan L, Shen C, Wu B, Luo J, Shen F, Zhao G. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value. Surgeon 2016;14:38-43. [PMID: 25263386 DOI: 10.1016/j.surge.2014.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Liu S, Zhou L, An L. Implementation of comprehensive rehabilitation therapy in postoperative care of patients with cholangiocarcinoma and its impact on patients' quality of life. Exp Ther Med 2019;17:2703-7. [PMID: 30906460 DOI: 10.3892/etm.2019.7215] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
18 Lytras D, Olde Damink SWM, Amin Z, Imber CJ, Malagó M. Radical Surgery in the Presence of Biliary Metallic Stents: Revising the Palliative Scenario. J Gastrointest Surg 2011;15:489-95. [DOI: 10.1007/s11605-010-1389-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
19 Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19:1602-1608. [PMID: 21964888 DOI: 10.1245/s10434-011-2077-5] [Cited by in Crossref: 159] [Cited by in F6Publishing: 138] [Article Influence: 14.5] [Reference Citation Analysis]
20 Bhardwaj N, Garcea G, Dennison AR, Maddern GJ. The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg 2015;39:2748-56. [PMID: 26133907 DOI: 10.1007/s00268-015-3125-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
21 Miura S, Kanno A, Fukase K, Tanaka Y, Matsumoto R, Nabeshima T, Hongou S, Takikawa T, Hamada S, Kume K, Kikuta K, Nakagawa K, Unno M, Masamune A. Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization. Surg Endosc 2020;34:667-74. [PMID: 31062157 DOI: 10.1007/s00464-019-06813-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011;8:189-200. [PMID: 21460876 DOI: 10.1038/nrgastro.2011.20] [Cited by in Crossref: 204] [Cited by in F6Publishing: 242] [Article Influence: 18.5] [Reference Citation Analysis]
23 Li J, Tan X, Zhang X, Zhao G, Hu M, Zhao Z, Liu R. Robotic radical surgery for hilar cholangiocarcinoma: A single-centre case series. Int J Med Robot 2020;16:e2076. [PMID: 31925864 DOI: 10.1002/rcs.2076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
24 Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013;257:718-725. [PMID: 23407295 DOI: 10.1097/sla.0b013e3182822277] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 9.4] [Reference Citation Analysis]
25 Hau HM, Meyer F, Jahn N, Rademacher S, Sucher R, Seehofer D. Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma. J Clin Med 2020;9:E3152. [PMID: 33003424 DOI: 10.3390/jcm9103152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Hyodo R, Suzuki K, Ebata T, Komada T, Mori Y, Yokoyama Y, Igami T, Sugawara G, Naganawa S, Nagino M. Assessment of percutaneous transhepatic portal vein embolization with portal vein stenting for perihilar cholangiocarcinoma with severe portal vein stenosis. J Hepatobiliary Pancreat Sci 2015;22:310-5. [DOI: 10.1002/jhbp.200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
28 Cao MT, Higuchi R, Yazawa T, Uemura S, Izumo W, Matsunaga Y, Sato Y, Morita S, Furukawa T, Egawa H, Yamamoto M. Narrowing of the remnant portal vein diameter and decreased portal vein angle are risk factors for portal vein thrombosis after perihilar cholangiocarcinoma surgery. Langenbecks Arch Surg 2021;406:1511-9. [PMID: 33409580 DOI: 10.1007/s00423-020-02044-1] [Reference Citation Analysis]
29 Liu Y, Li G, Lu Z, Wang T, Yang Y, Wang X, Liu J. Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis. PeerJ 2021;9:e12184. [PMID: 34631316 DOI: 10.7717/peerj.12184] [Reference Citation Analysis]
30 Hartog H, Ijzermans JN, van Gulik TM, Koerkamp BG. Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America 2016;96:247-67. [DOI: 10.1016/j.suc.2015.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
31 Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11999. [PMID: 30142840 DOI: 10.1097/MD.0000000000011999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
32 Berumen J, Hemming A. Vascular Reconstruction in Hepatic Malignancy. Surg Clin North Am 2016;96:283-98. [PMID: 27017865 DOI: 10.1016/j.suc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Bird NT, Manu N, Quinn L, Needham A, Jones R, Fenwick S, Poston G, Palmer D, Malik H. Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma. HPB 2019;21:1376-84. [DOI: 10.1016/j.hpb.2019.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 17.0] [Reference Citation Analysis]
35 Chung YK, Hwang S, Kim YI, Kang CM, Ko GY, Kwon DI, Lee SK. Spontaneous rupture of intrahepatic bile duct following portal vein embolization in a patient with perihilar cholangiocarcinoma: a case of successful curative resection. Korean J Hepatobiliary Pancreat Surg 2013;17:42-7. [PMID: 26155212 DOI: 10.14701/kjhbps.2013.17.1.42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-8. [PMID: 20945107 DOI: 10.1245/s10434-010-1325-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 128] [Article Influence: 11.9] [Reference Citation Analysis]
37 Groot Koerkamp B, Fong Y. Outcomes in biliary malignancy. J Surg Oncol. 2014;110:585-591. [PMID: 25250887 DOI: 10.1002/jso.23762] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
38 Kambakamba P, Deoliveira ML. Perihilar cholangiocarcinoma: paradigms of surgical management. The American Journal of Surgery 2014;208:563-70. [DOI: 10.1016/j.amjsurg.2014.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
39 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
40 Lee EC, Park SJ, Han SS, Shim JR, Park HM, Lee SD, Kim SH. Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2018;33:958-965. [PMID: 28843035 DOI: 10.1111/jgh.13966] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
41 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 100] [Article Influence: 16.2] [Reference Citation Analysis]
42 Akashi K, Ebata T, Mizuno T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Nagino M. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society? Surgery. 2018;164:1023-1029. [PMID: 30082134 DOI: 10.1016/j.surg.2018.05.051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
43 Mcmillan RR, Saharia A, Abdelrahim M, Ghobrial RM. New Breakthroughs for Liver Transplantation of Cholangiocarcinoma. Curr Transpl Rep 2021;8:21-7. [DOI: 10.1007/s40472-021-00313-6] [Reference Citation Analysis]
44 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354 [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
45 Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Br J Surg. 2018;105:829-838. [PMID: 28488733 DOI: 10.1002/bjs.10556] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 9.4] [Reference Citation Analysis]
46 Regimbeau JM, Fuks D, Le Treut YP, Bachellier P, Belghiti J, Boudjema K, Baulieux J, Pruvot FR, Cherqui D, Farges O; AFC-HC study group. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg. 2011;15:480-488. [PMID: 21249527 DOI: 10.1007/s11605-011-1414-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
47 Oh SG, Hwang S, Ha S, Kim H, Ryu LN. Necrosectomy of hepatic left lateral section after blunt abdominal trauma in a patient who underwent central hepatectomy and bile duct resection for perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2020;24:345-51. [PMID: 32843603 DOI: 10.14701/ahbps.2020.24.3.345] [Reference Citation Analysis]
48 Fukami Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Suzuki K, Nagino M. Diagnostic ability of MDCT to assess right hepatic artery invasion by perihilar cholangiocarcinoma with left-sided predominance. J Hepatobiliary Pancreat Sci 2012;19:179-86. [PMID: 21681648 DOI: 10.1007/s00534-011-0413-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
49 You Y, Heo JS, Shin SH, Shin SW, Park HS, Park KB, Cho SK, Hyun D, Han IW. Optimal timing of portal vein embolization (PVE) after preoperative biliary drainage for hilar cholangiocarcinoma. HPB (Oxford) 2021:S1365-182X(21)01631-2. [PMID: 34629262 DOI: 10.1016/j.hpb.2021.09.011] [Reference Citation Analysis]
50 Seehofer D, Kamphues C, Neuhaus P. [Resection of Klatskin tumors]. Chirurg 2012;83:221-8. [PMID: 22406679 DOI: 10.1007/s00104-011-2177-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
51 Fisher AV, Ronnekleiv-kelly SM. Surgical Management of Hilar Cholangiocarcinoma. Curr Surg Rep 2018;6. [DOI: 10.1007/s40137-018-0210-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach. Surgery 2018;163:732-8. [PMID: 29336813 DOI: 10.1016/j.surg.2017.08.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
53 Mekeel KL, Hemming AW. Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy. Hepat Oncol 2014;1:53-65. [PMID: 30190941 DOI: 10.2217/hep.13.5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17:691-699. [PMID: 26172136 DOI: 10.1111/hpb.12450] [Cited by in Crossref: 169] [Cited by in F6Publishing: 190] [Article Influence: 28.2] [Reference Citation Analysis]
55 Poruk KE, Pawlik TM, Weiss MJ. Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg 2015;19:1889-99. [PMID: 26022776 DOI: 10.1007/s11605-015-2854-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
56 Hwang S, Ha TY, Ko GY, Kwon DI, Song GW, Jung DH, Kim MH, Lee SK, Lee SG. Preoperative Sequential Portal and Hepatic Vein Embolization in Patients with Hepatobiliary Malignancy. World J Surg. 2015;39:2990-2998. [PMID: 26304608 DOI: 10.1007/s00268-015-3194-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
57 Abdelwahab M, El Nakeeb A, Salah T, Hamed H, Ali M, El Sorogy M, Shehta A, Ezatt H, Sultan AM, Zalata K. Hilar cholangiocarcinoma in cirrhotic liver: a case-control study. Int J Surg. 2014;12:762-767. [PMID: 24909136 DOI: 10.1016/j.ijsu.2014.05.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
58 Mitsuura C, Okabe H, Yamashita YI, Itoyama R, Yamao T, Umezaki N, Miyata T, Higashi T, Yamamura K, Nakagawa S, Imai K, Hayashi H, Chikamoto A, Baba H. A case of chest wall recurrence of hilar cholangiocarcinoma 10 years after R1 surgery with positive ductal margin of carcinoma in situ. Int Cancer Conf J 2020;9:77-81. [PMID: 32257758 DOI: 10.1007/s13691-020-00400-y] [Reference Citation Analysis]
59 Buettner S, van Vugt JL, Gani F, Groot Koerkamp B, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Guglielmi A, IJzermans JN, Pawlik TM. A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016;20:1716-1724. [PMID: 27412318 DOI: 10.1007/s11605-016-3203-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
60 Nagino M. Surgical Treatment of Perihilar Cholangiocarcinoma: Resection or Transplant? Ann Surg. 2018;267:806-807. [PMID: 29206670 DOI: 10.1097/sla.0000000000002624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
61 Yoo C, Shin SH, Park JO, Kim KP, Jeong JH, Ryoo BY, Lee W, Song KB, Hwang DW, Park JH, Lee JH. Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review. Cancers (Basel) 2021;13:1647. [PMID: 33916008 DOI: 10.3390/cancers13071647] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
62 Blechacz B. Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver. 2017;11:13-26. [PMID: 27928095 DOI: 10.5009/gnl15568] [Cited by in Crossref: 160] [Cited by in F6Publishing: 150] [Article Influence: 32.0] [Reference Citation Analysis]
63 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
64 Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162:500-514. [PMID: 28551378 DOI: 10.1016/j.surg.2017.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
65 Hau HM, Devantier M, Jahn N, Sucher E, Rademacher S, Seehofer D, Sucher R. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA). Cancers (Basel) 2021;13:4772. [PMID: 34638257 DOI: 10.3390/cancers13194772] [Reference Citation Analysis]
66 Ohiwa T, Ebata T, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. Occult synchronous liver metastasis from perihilar cholangiocarcinoma. Surgery 2019;166:290-6. [PMID: 31235246 DOI: 10.1016/j.surg.2019.04.029] [Reference Citation Analysis]
67 Patyutko YI, Polyakov AN, Podluzhnyi DV, Syskova AY, Sagaidak IV, Kotel'nikov AG, Sergeeva ON, Pokataev IA. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment]. Khirurgiia (Mosk) 2018;:30-7. [PMID: 30560842 DOI: 10.17116/hirurgia201812130] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Park GC, Lee SG, Yoon YI, Sung KB, Ko GY, Gwon DI, Jung DH, Jung YK. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2020;19:244-51. [PMID: 32414576 DOI: 10.1016/j.hbpd.2020.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Noji T, Tanaka K, Matsui A, Nakanishi Y, Asano T, Nakamura T, Tsuchikawa T, Okamura K, Hirano S. Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma. J Gastrointest Surg 2021. [PMID: 33403562 DOI: 10.1007/s11605-020-04891-1] [Reference Citation Analysis]
70 Cho MJ, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Lee SK, Kim MH, Lee SS, Park DH, Lee SG. Surgical experience of 204 cases of adult choledochal cyst disease over 14 years. World J Surg. 2011;35:1094-1102. [PMID: 21360306 DOI: 10.1007/s00268-011-1009-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
71 Hoyos S, Navas MC, Restrepo JC, Botero RC. Current controversies in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1461-1467. [PMID: 28756216 DOI: 10.1016/j.bbadis.2017.07.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
72 Cillo U, Fondevila C, Donadon M, Gringeri E, Mocchegiani F, Schlitt HJ, Ijzermans JNM, Vivarelli M, Zieniewicz K, Olde Damink SWM, Groot Koerkamp B. Surgery for cholangiocarcinoma. Liver Int 2019;39 Suppl 1:143-55. [PMID: 30843343 DOI: 10.1111/liv.14089] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
73 Hu HJ, Mao H, Tan YQ, Shrestha A, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma. Springerplus. 2016;5:551. [PMID: 27190750 DOI: 10.1186/s40064-016-2181-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
74 Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M. Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases. J Hepatobiliary Pancreat Sci 2019;26:490-502. [PMID: 31520452 DOI: 10.1002/jhbp.668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
75 Hu HJ, Jin YW, Zhou RX, Shrestha A, Ma WJ, Yang Q, Wang JK, Liu F, Cheng NS, Li FY. Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required? J Gastrointest Surg. 2018;22:1204-1212. [PMID: 29512002 DOI: 10.1007/s11605-018-3711-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
76 Kleive D, Berstad AE, Verbeke CS, Haugvik SP, Gladhaug IP, Line PD, Labori KJ. Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery. HPB (Oxford) 2016;18:615-22. [PMID: 27346143 DOI: 10.1016/j.hpb.2016.05.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
77 Yu W, Gu Z, Shi S, Shen N, Zhang Y. Effect evaluation of vascular resection for patients with hilar cholangiocarcinoma: original data and meta-analysis. Cell Biochem Biophys 2014;69:509-16. [PMID: 24510536 DOI: 10.1007/s12013-014-9825-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
78 de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012;118:4737-4747. [PMID: 22415526 DOI: 10.1002/cncr.27492] [Cited by in Crossref: 119] [Cited by in F6Publishing: 112] [Article Influence: 11.9] [Reference Citation Analysis]
79 Bagante F, Tran T, Spolverato G, Ruzzenente A, Buttner S, Ethun CG, Groot Koerkamp B, Conci S, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Vitiello G, IJzermans JN, Maithel SK, Poultsides G, Guglielmi A, Pawlik TM. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. J Am Coll Surg. 2016;222:750-759.e2. [PMID: 27113512 DOI: 10.1016/j.jamcollsurg.2016.02.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
80 Khuntikeo N, Pugkhem A, Titapun A, Bhudhisawasdi V. Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience. J Hepatobiliary Pancreat Sci. 2014;21:521-524. [PMID: 24464976 DOI: 10.1002/jhbp.74] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
81 Shen J, Wang W, Wu J, Feng B, Chen W, Wang M, Tang J, Wang F, Cheng F, Pu L. Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma. PLoS One. 2012;7:e47476. [PMID: 23118872 DOI: 10.1371/journal.pone.0047476] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
82 Shin D, Lee S, Lee JH, Hong SM, Park SY, Yoo C, Lee W, Song KB, Hwang DW, Kim SC. Prognostic implication of high grade biliary intraepithelial neoplasia in bile duct resection margins in patients with resected perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2020;27:604-13. [PMID: 32639085 DOI: 10.1002/jhbp.800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Hwang S. Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:112-21. [PMID: 33649263 DOI: 10.14701/ahbps.2021.25.1.112] [Reference Citation Analysis]
84 Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28:226-231. [PMID: 21540611 DOI: 10.1159/000327361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
85 Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, Lau WY, Shen F, Huang DS, Zhang CW, Yang T. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Ther Adv Gastrointest Endosc 2021;14:2631774521993065. [PMID: 33629062 DOI: 10.1177/2631774521993065] [Reference Citation Analysis]
86 Kow AW, Wook CD, Song SC, Kim WS, Kim MJ, Park HJ, Heo JS, Choi SH. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg. 2012;36:1112-1121. [PMID: 22374541 DOI: 10.1007/s00268-012-1497-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
87 Hosokawa I, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M. Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy. Ann Surg. 2014;259:1178-1185. [PMID: 24509210 DOI: 10.1097/sla.0000000000000584] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
88 Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol. 2014;40:489-495. [PMID: 24685155 DOI: 10.1016/j.ejso.2014.02.231] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
89 Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 2011;212:604-13; discussion 613-6. [PMID: 21463797 DOI: 10.1016/j.jamcollsurg.2010.12.028] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
90 Neumann UP, Schmeding M. Role of surgery in cholangiocarcinoma: From resection to transplantation. Best Pract Res Clin Gastroenterol. 2015;29:295-308. [PMID: 25966429 DOI: 10.1016/j.bpg.2015.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
91 Bird NTE, McKenna A, Dodd J, Poston G, Jones R, Malik H. Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. Br J Surg. 2018;105:1408-1416. [PMID: 29999515 DOI: 10.1002/bjs.10921] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
92 Takahashi Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical treatment of perihilar cholangiocarcinoma in octogenarians: a single center experience. Journal of Hepato-Biliary-Pancreatic Sciences 2013;20:324-31. [DOI: 10.1007/s00534-012-0529-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
93 Pinotti E, Sandini M, Famularo S, Tamini N, Romano F, Gianotti L. Resection of the caudate lobe for the treatment of hilar cholangiocarcinoma. Minerva Chir 2019;74:348-58. [PMID: 29658674 DOI: 10.23736/S0026-4733.18.07498-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Donati M, Stang A, Stavrou GA, Basile F, Oldhafer KJ. Extending resectability of hilar cholangiocarcinomas: how can it be assessed and improved? Future Oncol 2019;15:193-205. [PMID: 30378439 DOI: 10.2217/fon-2018-0413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
95 Li O, Yi W, Yang P, Guo C, Peng C. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients. Acta Cir Bras 2019;34:e201900409. [PMID: 31038586 DOI: 10.1590/s0102-865020190040000009] [Reference Citation Analysis]
96 Krampitz GW, Aloia TA. Staging of Biliary and Primary Liver Tumors. Surgical Oncology Clinics of North America 2019;28:663-83. [DOI: 10.1016/j.soc.2019.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Hwang S, Song GW, Ha TY, Lee YJ, Kim KH, Ahn CS, Sung KB, Ko GY, Kim MH, Lee SK, Moon DB, Jung DH, Park GC, Lee SG. Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer. World J Surg 2012;36:379-85. [PMID: 22159824 DOI: 10.1007/s00268-011-1364-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
98 Zhang XF, Beal EW, Chakedis J, Chen Q, Lv Y, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Buettner S, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium. World J Surg 2018;42:2919-29. [PMID: 29404753 DOI: 10.1007/s00268-018-4530-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
99 Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159-171. [PMID: 25376337 DOI: 10.1007/s00384-014-2063-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
100 Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg. 2012;255:754-762. [PMID: 22367444 DOI: 10.1097/sla.0b013e31824a8d82] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
101 Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, Seo DW, Pantongrag-Brown L, Sangchan A, Pisespongsa P, Akaraviputh T, Reddy ND, Maydeo A, Itoi T, Pausawasdi N, Punamiya S, Attasaranya S, Devereaux B, Ramchandani M, Goh KL; Asia-Pacific Working Group on Hepatobiliary Cancers. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593-607. [PMID: 23350673 DOI: 10.1111/jgh.12128] [Cited by in Crossref: 135] [Cited by in F6Publishing: 113] [Article Influence: 15.0] [Reference Citation Analysis]
102 Hu HJ, Mao H, Shrestha A, Tan YQ, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. World J Gastroenterol 2016; 22(8): 2601-2610 [PMID: 26937148 DOI: 10.3748/wjg.v22.i8.2601] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
103 Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol. 2014;26:1047-1054. [PMID: 25051217 DOI: 10.1097/meg.0000000000000162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
104 Nagino M, Hirano S, Yoshitomi H, Aoki T, Uesaka K, Unno M, Ebata T, Konishi M, Sano K, Shimada K, Shimizu H, Higuchi R, Wakai T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 2021;28:26-54. [PMID: 33259690 DOI: 10.1002/jhbp.870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
105 Ota Y, Matsuyama R, Taniguchi K, Ueda M, Takeda K, Tanaka K, Nakayama T, Endo I. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clin J Gastroenterol 2013;6:485-9. [PMID: 24319501 DOI: 10.1007/s12328-013-0432-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Otsuka S, Ebata T, Yokoyama Y, Mizuno T, Tsukahara T, Shimoyama Y, Ando M, Nagino M. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma. British Journal of Surgery 2019;106:774-82. [DOI: 10.1002/bjs.11125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
107 Khan AS, Dageforde LA. Cholangiocarcinoma. Surg Clin North Am. 2019;99:315-335. [PMID: 30846037 DOI: 10.1016/j.suc.2018.12.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
108 Lee JH, Hwang DW, Lee SY, Park K, Lee Y. The Proximal Margin of Resected Hilar Cholangiocarcinoma: The Effect of Microscopic Positive Margin on Long-Term Survival. The American Surgeon 2012;78:471-7. [DOI: 10.1177/000313481207800440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
109 Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection. Onco Targets Ther 2017;10:2257-66. [PMID: 28461760 DOI: 10.2147/OTT.S131873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
110 Mao K, Liu J, Sun J, Zhang J, Chen J, Pawlik TM, Jacobs LK, Xiao Z, Wang J. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2016;31:417-426. [PMID: 26250532 DOI: 10.1111/jgh.13072] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
111 Mehrotra S, Lalwani S, Nundy S. Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions. Hepat Med 2020;12:1-13. [PMID: 32158282 DOI: 10.2147/HMER.S223022] [Reference Citation Analysis]
112 Lee SH, Choi GH, Han DH, Kim KS, Choi JS, Rho SY. Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:62-70. [PMID: 33649256 DOI: 10.14701/ahbps.2021.25.1.62] [Reference Citation Analysis]
113 Watanabe N, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Nagino M. Postoperative Pancreatic Fistula in Surgery for Perihilar Cholangiocarcinoma. World J Surg 2019;43:3094-100. [PMID: 31407095 DOI: 10.1007/s00268-019-05127-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
114 Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MG, Blumgart LH, Busch OR, D'Angelica MI, DeMatteo RP. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol. 2015;26:1930-1935. [PMID: 26133967 DOI: 10.1093/annonc/mdv279] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
115 Hwang S. Parenchyma-preserving hepatectomy including segments I + IV resection and bile duct resection in a patient with type IV perihilar cholangiocarcinoma: A case report with video clip. Ann Hepatobiliary Pancreat Surg 2021;25:419-25. [PMID: 34402446 DOI: 10.14701/ahbps.2021.25.3.419] [Reference Citation Analysis]
116 DeOliveira ML, Kambakamba P, Clavien PA. Advances in liver surgery for cholangiocarcinoma. Curr Opin Gastroenterol. 2013;29:293-298. [PMID: 23563982 DOI: 10.1097/mog.0b013e3283600a92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
117 Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg 2016; 8(6): 436-443 [PMID: 27358676 DOI: 10.4240/wjgs.v8.i6.436] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
118 Weiss MJ, Cosgrove D, Herman JM, Rastegar N, Kamel I, Pawlik TM. Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg. 2014;399:679-692. [PMID: 24962146 DOI: 10.1007/s00423-014-1219-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
119 de Santibañes E, Ardiles V, Alvarez FA, Pekolj J, Brandi C, Beskow A. Hepatic artery reconstruction first for the treatment of hilar cholangiocarcinoma bismuth type IIIB with contralateral arterial invasion: a novel technical strategy. HPB (Oxford) 2012;14:67-70. [PMID: 22151454 DOI: 10.1111/j.1477-2574.2011.00404.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
120 Miura F, Sano K, Amano H, Toyota N, Wada K, Tokairin T, Kondo F, Hayano K, Matsubara H, Takada T. Is it possible to define early distal cholangiocarcinoma? Langenbecks Arch Surg 2016;401:25-32. [DOI: 10.1007/s00423-015-1351-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Höckerstedt K. What is new in liver surgery? Scand J Surg 2011;100:5-7. [PMID: 21482499 DOI: 10.1177/145749691110000102] [Reference Citation Analysis]
122 Lytras D, Kalaitzakis E, Webster GJ, Imber CJ, Amin Z, Rodriguez-Justo M, Pereira SP, Olde Damink SW, Malagoʼ M. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions? Ann Surg 2012;256:1059-67. [PMID: 22580936 DOI: 10.1097/SLA.0b013e3182533a0a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
123 Wu X, Dong P, Gu J, Li M, Wu W, Lu J, Mu J, Ding Q, Zhang L, Ding Q, Weng H, Liu Y. Combined Portal Vein Resection for Hilar Cholangiocarcinoma: A Meta-analysis of Comparative Studies. J Gastrointest Surg 2013;17:1107-15. [DOI: 10.1007/s11605-013-2202-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
124 Jo HS, Kim DS, Yu YD, Kang WH, Yoon KC. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study. World J Surg Oncol 2020;18:3. [PMID: 31901228 DOI: 10.1186/s12957-019-1779-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Mizuno T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Yamaguchi J, Nagino M. Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis. Surg Today 2017;47:182-92. [DOI: 10.1007/s00595-016-1354-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
126 Ravaioli M, Ercolani G, Neri F, Cescon M, Stacchini G, Gaudio MD, Cucchetti A, Pinna AD. Liver transplantation for hepatic tumors: A systematic review. World J Gastroenterol 2014; 20(18): 5345-5352 [PMID: 24833864 DOI: 10.3748/wjg.v20.i18.5345] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
127 Boilève A, Hilmi M, Delaye M, Tijeras-Raballand A, Neuzillet C. Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice? Cancers (Basel) 2021;13:2708. [PMID: 34070929 DOI: 10.3390/cancers13112708] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Hwang S, Ko GY, Kim MH, Lee SK, Gwon DI, Ha TY, Song GW, Jung DH, Park DH, Lee SS. Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients. World J Surg 2016;40:2758-65. [PMID: 27384172 DOI: 10.1007/s00268-016-3618-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
129 She WH, Cheung TT, Ma KW, Tsang SHY, Dai WC, Chan ACY, Lo CM. Vascular resection and reconstruction in hilar cholangiocarcinoma. ANZ J Surg 2020;90:1653-9. [PMID: 32458528 DOI: 10.1111/ans.15969] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
130 Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17:913-924. [PMID: 23319395 DOI: 10.1007/s11605-013-2144-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
131 Lamarca A, Edeline J, McNamara MG, Hubner RA, Nagino M, Bridgewater J, Primrose J, Valle JW. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat Rev. 2020;84:101936. [PMID: 31986437 DOI: 10.1016/j.ctrv.2019.101936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
132 Hong SS, Han DH, Choi GH, Choi JS. Comparison study for surgical outcomes of right versus left side hemihepatectomy to treat hilar cholangiocellular carcinoma. Ann Surg Treat Res 2020;98:15-22. [PMID: 31909046 DOI: 10.4174/astr.2020.98.1.15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Regimbeau JM, Fuks D, Pessaux P, Bachellier P, Chatelain D, Diouf M, Raventos A, Mantion G, Gigot JF, Chiche L. Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford). 2015;17:79-86. [PMID: 24992279 DOI: 10.1111/hpb.12296] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
134 Sano T, Shimizu Y, Senda Y, Komori K, Ito S, Abe T, Kinoshita T, Nimura Y. Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg 2013;398:1145-50. [PMID: 24026222 DOI: 10.1007/s00423-013-1110-5] [Reference Citation Analysis]
135 Dumitrascu T, Brasoveanu V, Stroescu C, Ionescu M, Popescu I. Major hepatectomies for perihilar cholangiocarcinoma: Predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions. Asian J Surg. 2016;39:81-89. [PMID: 26103932 DOI: 10.1016/j.asjsur.2015.04.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
136 Fukami Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Salvage hepatectomy for perihilar malignancy treated initially with biliary self-expanding metallic stents. Surgery. 2013;153:627-633. [PMID: 23270971 DOI: 10.1016/j.surg.2012.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
137 Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg. 2018;267:797-805. [PMID: 29064885 DOI: 10.1097/sla.0000000000002574] [Cited by in Crossref: 68] [Cited by in F6Publishing: 33] [Article Influence: 22.7] [Reference Citation Analysis]
138 Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129-140. [PMID: 23059502 DOI: 10.1097/sla.0b013e3182708b57] [Cited by in Crossref: 321] [Cited by in F6Publishing: 146] [Article Influence: 35.7] [Reference Citation Analysis]
139 Zhang XF, Squires MH 3rd, Bagante F, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Weiss M, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma. Ann Surg Oncol 2018;25:1140-9. [PMID: 29470820 DOI: 10.1245/s10434-018-6382-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
140 Lee Y, Choi D, Han S, Han IW, Heo JS, Choi SH. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:350-8. [PMID: 30588526 DOI: 10.14701/ahbps.2018.22.4.350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
141 Giuliante F, Ardito F, Aldrighetti L, Ferrero A, Pinna AD, De Carlis L, Cillo U, Jovine E, Portolani N, Gruttadauria S, Mazzaferro V, Massani M, Rosso E, Ettorre GM, Ratti F, Guglielmi A, Cescon M, Colasanti M, Di Sandro S, Gringeri E, Russolillo N, Ruzzenente A, Sposito C, Zanello M, Zimmitti G; Italian Association of HepatoBilioPancreatic Surgeons-AICEP., Italian Association of Hepato-Biliary-Pancreatic Surgeons-AICEP. Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study. Surgery 2021;170:383-9. [PMID: 33622570 DOI: 10.1016/j.surg.2021.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Vogel A, Wege H, Caca K, Nashan B, Neumann U. The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int. 2014;111:748-754. [PMID: 25412632 DOI: 10.3238/arztebl.2014.0748] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
143 Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy. Langenbecks Arch Surg 2016;401:503-11. [DOI: 10.1007/s00423-016-1427-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
144 Seki T, Igami T, Ebata T, Yokoyama Y, Sugawara G, Suzumura K, Nagino M. Six-year survival following left hepatic trisectionectomy with simultaneous resection of the portal vein and right hepatic artery for advanced perihilar cholangiocarcinoma without lymph node metastases: report of a case. Clin J Gastroenterol 2012;5:327-31. [PMID: 26181070 DOI: 10.1007/s12328-012-0322-5] [Reference Citation Analysis]
145 Matsuyama R, Mori R, Ota Y, Homma Y, Kumamoto T, Takeda K, Morioka D, Maegawa J, Endo I. Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction. Ann Surg Oncol 2016;23:475-84. [PMID: 27387681 DOI: 10.1245/s10434-016-5381-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
146 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
147 Boudjema K, Sulpice L, Garnier S, Bretagne J, Gandon Y, Rohou T. A Simple System to Predict Perihilar Cholangiocarcinoma Resectability. J Gastrointest Surg 2013;17:1247-56. [DOI: 10.1007/s11605-013-2215-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
148 Oguro S, Esaki M, Kishi Y, Nara S, Shimada K, Ojima H, Kosuge T. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma. Ann Surg Oncol 2015;22:1915-24. [PMID: 25404474 DOI: 10.1245/s10434-014-4232-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
149 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Higuchi R, Ota T, Yazawa T, Kajiyama H, Araida T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M. Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today 2016;46:74-83. [DOI: 10.1007/s00595-015-1119-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
151 Hwang S, Jung SW, Namgoong JM, Yoon SY, Park GC, Jung DH, Song GW, Ha TY, Ko GY, Suh DW, Lee SG. Solitary percutaneous transhepatic biliary drainage tract metastasis after curative resection of perihilar cholangiocarcinoma: report of a case. Korean J Hepatobiliary Pancreat Surg 2011;15:179-83. [PMID: 26421036 DOI: 10.14701/kjhbps.2011.15.3.179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
152 Nakahashi K, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Watanabe N, Nagino M. How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma? Surgery 2020;168:617-24. [PMID: 32665142 DOI: 10.1016/j.surg.2020.04.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
153 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Sakabe R, Kobayashi H, Kondo N, Nakagawa N, Sueda T. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. J Hepatobiliary Pancreat Sci. 2012;19:306-313. [PMID: 22270151 DOI: 10.1007/s00534-011-0498-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
154 Titapun A, Luvira V, Srisuk T, Jareanrat A, Thanasukarn V, Thanee M, Sa-Ngiamwibool P, Padthaisong S, Duangkumpha K, Suksawat M, Loilome W, Sithithaworn P, Techasen A, Thinkhamrop B, Dzienny A, Caglayan A, Park D, Mahmud S, Khuntikeo N. High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. Int J Gen Med 2021;14:2191-204. [PMID: 34103974 DOI: 10.2147/IJGM.S306339] [Reference Citation Analysis]
155 Boudjema K, Levi Sandri GB, Boucher E, Rohou T, Rayar M, Sulpice L. An update on liver surgery for cholangiocarcinoma. Updates Surg 2014;66:93-100. [DOI: 10.1007/s13304-013-0235-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]